Evaluation of the efficacy of labor induction with vaginal misoprostol in a low-risk pregnant women population.
Letícia Sampaio Vilas-Boas, Marcos Paulo Ribeiro Sanches, Edward Araujo Júnior...
https://pubmed.ncbi.nlm.nih.gov/39045936Actively Recruiting
Led by Cairo University · Updated on 2025-08-07
150
Participants Needed
1
Research Sites
2 weeks
Total Duration
Researchers are evaluating the effect of dexamethasone on labour induction in women with term pregnancies. This randomized controlled trial includes pregnant women over 18 years old who are eligible for labour induction. The study aims to compare the time from the start of labour induction to the beginning of the active phase, as well as secondary outcomes like duration of active labour, second stage of labour, delivery methods, and fetal outcomes. Participants are randomly divided into three groups. Group A receives one intramuscular dose of dexamethasone sodium phosphate 8 mg (2 mL). Group B receives vaginal misoprostol 25 mcg tablets every 6 hours, up to 4 tablets within 24 hours. Group C receives both the IM dexamethasone dose and the vaginal misoprostol schedule. After dosing, a senior obstetrician reassesses participants 24 hours after the last dose to decide next steps if induction is unsuccessful. During the study, participants undergo detailed medical history and physical exams, including fetal well-being checks and cervical assessments. Researchers monitor labour progress hourly for up to 24 hours, document labour stages, delivery mode, and fetal condition at 1 and 5 minutes after birth. Safety and fetal outcomes are recorded within 24 hours post-delivery. The total participation duration corresponds to the induction process and immediate delivery outcomes.
CONDITIONS
Effect of Dexamethasone on Labour Induction in Term Pregnancies
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for consent, medical history, physical and abdominal exams, local and sonographic assessments
Duration - Up to 48 hours including induction and reassessment
Participants receive induction of labour using one of three interventions: a single dose of dexamethasone injection, vaginal misoprostol tablets every 6 hours for up to 24 hours, or a combination of both. After the last dose, participants are reassessed for labour progress.
Treatment occurs in hospital with monitoring during induction and reassessment after 24 hours
Duration - Up to 24 hours after delivery
Participants are monitored through delivery to assess labour duration, mode of delivery, and fetal outcomes up to 24 hours after birth.
Assessments at delivery and at 1 and 5 minutes after delivery, plus monitoring within 24 hours postpartum
Total: 1 location
1
Cairo University Hospital (Kasr Al Ainy)
Cairo, Manial, Egypt, 11562
Actively Recruiting
A
Abdelfatah M Eldesouky, MD, MRCOG
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Letícia Sampaio Vilas-Boas, Marcos Paulo Ribeiro Sanches, Edward Araujo Júnior...
https://pubmed.ncbi.nlm.nih.gov/39045936Fatemeh Laloha, Negin Mahboob Asiabar, Ameneh Barikani...
https://pubmed.ncbi.nlm.nih.gov/26553085Zaynab Mohaghegh, Shahla Faal Siahkal, Hadis Bahmaei...
https://pubmed.ncbi.nlm.nih.gov/34404372J Kavanagh, A J Kelly, J Thomas
https://pubmed.ncbi.nlm.nih.gov/16625570